Renata PLC (DSE: RENATA)
Health Care · Pharmaceuticals · BD
Tk449.90
+0.27% today · -3.8% 1Y
Renata PLC (DSE: RENATA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $418.98M.
Over the last twelve months the share price has lost 3.8%, trading between 372.00 and 488.00.
Tweenvest scores Renata PLC across four factors: quality 69/100, value 64/100, growth 22/100, dividend 28/100. Its strongest factor is quality.
RENATA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $418.98M
- Revenue (TTM)
- $366.42M
- P/E
- 18.90
- EPS
- 23.81
- Dividend yield
- 1.22%
- Beta (5Y)
- 0.00
- 52-week high
- Tk488.00
- 52-week low
- Tk372.00
- Avg volume (3M)
- —
- Shares outstanding
- 114.70M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $427.35M | CN¥6.16 | +0.82% |
| Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim SirketiIBSE: GENIL | $425.91M | TL4.67 | -11.89% |
| Lumosa Therapeutics Co., Ltd.TPEX: 6535 | $425.85M | NT$81.30 | -4.35% |
| Gufic Biosciences LimitedBSE: 509079 | $419.45M | Rs404.80 | -3.20% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671 | $416.71M | CN¥22.92 | +5.19% |
| Chengdu huasun technology group Inc. , LTD.SZSE: 000790 | $413.45M | CN¥4.44 | +0.45% |
| Atea Pharmaceuticals, Inc.NasdaqGS: AVIR | $413.05M | $5.15 | -0.10% |
| JCR Pharmaceuticals Co., Ltd.TSE: 4552 | $407.69M | ¥529.00 | +9.52% |
Figures last refreshed Oct 11, 2026.